際際滷

際際滷Share a Scribd company logo
LEPTOSPIROSIS
INTRODUCTION
 Leptospirosis is a zoonotic disease with protean manifestations
 Common synonyms include weils disease , rice field fever
 Mild disease to extremely fatal
 Imperative to suspect and treat early in order to prevent complications
EPIDEMIOLOGY
 Occurs most commonly in tropics and sub tropics
 Around 1 million cases reported yearly worldwide with mean case fatality rate
of about 10%
AGENT
 Leptospira (thin,spiral ) are spirochetes belonging to the order spirochaetales
 Nearly 64 species have been identified ,divided into 2 clades and 4 sub clades
(p1,p2,s1,s2)
 Traditionally classified as pathogenic (l.Interrogans) and free living (l. Biflexa)
 260 serovars
LEPTOSPIROSIS
 1.6- 20 micron long and 0.1 micron
wide
 2. Two polar extrusions
 3.Dark field microscopy / silver
impregnation staining
 4.Special culture media ( fletcher's
, Ellinghausen mccullough  johnson-
harris , or polysorbate 80)
HOST
 Mammals are natural host
 Humans are incidental hosts ( animal or environmental exposure)
 Rodents can persistently shed leptospires in urine throughout their lifespan
HOST  RISK FACTORS
 Men are more commonly infected
 Low socioeconomic status - overcrowding and unhygenic
 Barefoot walking (cuts/abrasions)
 Recreational exposure - rafting , fresh water swimming
 Occupational exposure - farmers , sewage workers
 Domestic animal exposure
 Travel to endemic areas
TRANSMISSION TO
HUMANS
ENVIRONMENT
 Damp soil and water
 Temperature of 28-32 celsius
 Tropical regions
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
PATHOGENESIS
CLINICAL FEATURES MILD DISEASE
 Majority of cases are mild and go undiagnosed
 Acute febrile illness / flu like syndrome
 Fever,headache,rigors,cough
 Myalgia- calves,backand abdomen
CLINICAL FEATURES
 Conjunctival suffusion
 Pharyngeal congestion
 Muscle tenderness
 Hepatosplenomegaly, lymphadenopathy
 Meningismus
 Transient rash
SEVERE LEPTOSPIROSIS AND
COMPLICATIONS
 Onset similar to mild disease
 May not respect the biphasic course of illness
 Mortality can be as high as 50%
SEVERE LEPTOSPIROSIS
 Hemorrhage
 Acute renal failure
 Acute respiratory failure
 Multiorgan failure
 Weil syndrome  Triad of hemorrhage , jaundice and
acute kidney injury
 SHOCK  common presenting sign (45%) due to
hypovolemia and microvascular dysregulation
CIRCULATORY DYSFUNCTION
 Hypovolemia occurs in sepsis causes vascular leakage or
occur as a consequence of hemorahage
 Shock
 Multiorgan dysfunction
 Hemorrhage manifests due to thrombocytopenia ,
coagulopathy,vascular endothelial damage
RENAL INVOLVEMENT
 Renal impairment attenuated by dehydration from low fluid intake and high fever
 Occurs together with jaundice within first 3-4 days presents as non-oliguric
,oliguric or anuric
 Hyponatremia and hypokalemia due to tubulopathy involving NA-K-2Cl
cotransporter
 Hypokalemia due to impairment of sodium transporter in proximal tubules and
spared distal tubules is more common
 Hypomagnesemia
RENAL INVOLVEMENT
POLYURIC PHASE:
 Develop after 10-18 days
 S.creatinine begins to fall at the end of second
week and normalizes within 3-5 weeks
 In mild cases the only abnormal findings are in
urinary sediment includes albuminuria,
microscopic hematuria,pyuria and granular casts
PULMONARY INVOLVEMENT
Occurs in 20-70% of cases
Most common symptom is cough
Blood tinged sputum or obvious hemoptysis occur
Pulmonary hemorrhage  minimal or severe diffused leading to respiratory
failure
Pulmonary edema with cardiomegaly due to volume overload or congestive
heart failure from myocarditis
Diffuse ground glass opacities without cardiomegaly - ARDS
CARDIAC INVOLVEMENT
 Most commonly non specific st-t changes
 Myocarditis
 Conduction abnormality
 Repolarization abnormalities and arrhthmias
CNS INVOLVEMENT
 Aseptic lymphocytic meningitis
 Leptospira can be isolated from CSF within 5 days
after onset of fever
 Raised CSF opening pressure Raised protein with
normal CSF glucose level
 Lymphocytic pleocytosis
 Encephalomyelitis
 Guillain Barre syndrome
 Mononeuritis multiplex
 Cranial nerve palsy
 Psychiatric syndrome  Mania
LABORATORY DIAGNOSIS
 Complete Blood Count
 Renal Function Tests
 Liver Function Tests
 CPK
 CSF Analysis
 Urine Analysis
 CXR,ECG
 PT,APTT
 TESTS FOR DIAGNOSIS OF LEPTOSPIROSIS
LABORATORY DIAGNOSIS
 CBC- Leucocytosis( N- 80%)+thrombocytopenia,
anaemia++ Thrombocytopenia is a indicator of
severe disease.
 LFT- Elevated billirubin, elevated liver enzymes
 Markedly Elevated cpk
 PT, APTT- Prolonged.
 RFT- AKI+
 Urine analysis- proteinuria+, rbcs+
 CSF ANALYSIS- ASEPTIC MENINGITIS
SUPPORTIVE TESTS
 Elevated serum amylase
 Elevated creatinine kinase
 Cardiac biomarkers
 Elevated ESR/CRP/Procalcitonin
PULMONARY LEPTOSPIROSIS
HRCT CHEST
 Patchy alveolar infiltration
Ground glass attenuation
Interlobular septa thickening
Mediastinal lymphadenitis
LABORATORY DIAGNOSIS - SPECIFIC
 Direct isolation
 PCR - sensitivity 45-55%
Specificity 99-100%
Can detect even in first five days of illness
Can be done in blood /urine/csf
 Culture - specificity- 100%
Sensitivity - 25%
Requires special media
Time consuming
Blood /csf - first 10 days
Urine - 2nd week to 30 days after resolution of illness
SEROLOGICAL DIAGNOSIS
Microscopic agglutination test (mat)
 Four fold rise in titre or single value of 1:800
 Sensitivity  16-20%
Igm-elisa
 Simple , sensitive
 Single positive sample adequate for diagnosis becomes positive earlier than mat
 Indicates current infection
 Commonly performed
Antigen detection:
 Using monoclonal anti lipl32 antibody based antigen capture ellisa- a cost effective alternative to
pcr.
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT
LAB CRITERIA FOR DIAGNOSIS OF CURRENT
LEPTOSPIROSIS
CULTURE POSITIVE
 MAT-SEROCONVERSION
 ELISA -POSITIVE
MODIFIED
FAINE'S
SCORE
 Presumptive diagnosis of leptospirosis is made of:
 Part A or Part A + B Score : 26 or more
 Part A+B+C (Total) : 25 or more
 A score between 20 and 25 suggests Leptospirosis as a possible
diagnosis.
 Part A+B is useful for diagnosis in the first week as lab tests would be
negative.
 Part A+B+C is valuable in the second week as lab tests would become
positive.
 It is always necessary to confirm the diagnosis with laboratory tests.
Reason for Modification
 Most cases of leptospirosis are reported in the monsoon and post
monsoon seasons. Therfore factors such as rainfall,and contact with
contaminated environment have been incorporated with appropriate
scores Part (B)
 ELISA and SAT measures IgM antibodies becomes positive by 5th
day ,they are the test of choice for diagnosis of current infection and
more over a single sample is adequate . High titres and rising titres of
MAT have been given appropriate scores Part (C)
MANAGEMENT
 MILD LEPTOSPIROSIS:
 FIRST LINE - Doxycycline 100mg BID PO for 10 days
 ALTERNATIVE 
 Amoxicillin 500mg QID OR 1g q8h
OR
 AMPICILLIN 500MG PO tid
OR
 Azithromycin 1g initially followed by 500 mg OD for 2
more days
SEVERE LEPTOSPIROSIS(WEIL SYNDROME)
PRIMARY :
 Penicillin G 1.5 million units IV q 6 hrs for 7 days
 Ceftriaxone 1gm IV OD for 7 days
ALTERNATIVE :
 Ampicillin 0.5-1 gm q6h
 Azithromycin 500mg OD for 5 days
 Cefotaxime 1gm q6h
 Doxycycline 200mg iv loading dose followed by 100mg iv q12h
ROLE OF STEROIDS
WHY
 To reduce or delay the need for ventillatory support
 To reduce mortality
WHOM
 Patients at high risk of pulmonary hemorrhage
 AKI plus any of the following
Platelet count < 1 lakh
MAP < 65 mm of Hg
Prolonged PT/APTT
Need for ionotropes
When
 Initiate as soon as first sign of pulmonary leptospirosis is detected (
tachypnea, hemoptysis, dyspnea)
STEROID REGIMENS
 Methylprednisolone 500mg IV OD for 3 days with first
dose given as bolus within first 12 hrs of onset of
respiratory involvement
 For those with renal failure  Methylprednisolone 500mg IV
after HD OD for 3 days.
After 3rd MP dose or after any episode of hemoptysis give
Cyclophosphamide 1g IV as single dose
 Bolus Methylprednisolone 1g IV OD for 3 das followed b
1mg/kg/day of oral prednisolone for 7 days
PREVENTION AND CONTROL
 Avoid swimming,bathing ,swallowing or submersing head in potentially
contaminated freshwater especially after periods of heavy rainfall or
flooding
 Rodent control measures
 Chemoprophylaxis with weekly doxycycline 200 mg once weekly
for 6 weeks
 Proper drainage of water bodies
 Vaccination of domestic animals
 General protective measures ( proper footwear,eyewear,bandage of
cuts ,etc)
PROGNOSIS - POOR FACTORS
 AGE>40 YEARS
 CNS/PULMONARY /SEVERE RENAL INVOLVEMENT
 MECHANICAL VENTILATION
 ARRHYTHMIAS AND REPOLARISATION ABNORMALITIES
 SHOCK
 LEUCOCYTOSIS
REFERENCE
 MANSON TROPICAL INFECTION
 HARRISON 21ST EDITION
LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT

More Related Content

Similar to LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT (20)

lecture notes
lecture noteslecture notes
lecture notes
john522129
Lupus nephritis post fff
Lupus nephritis  post fffLupus nephritis  post fff
Lupus nephritis post fff
Faculty of Medicine, Ain Shams University
Pulmonary Sarcoidosis
Pulmonary SarcoidosisPulmonary Sarcoidosis
Pulmonary Sarcoidosis
Sarfraz Saleemi
Leptospirosis notes IM full notes with clinical
Leptospirosis notes IM full notes with clinicalLeptospirosis notes IM full notes with clinical
Leptospirosis notes IM full notes with clinical
drvimalan524
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
dlecolst
Hypereosinophilia overview - pediatric resident
Hypereosinophilia overview - pediatric resident Hypereosinophilia overview - pediatric resident
Hypereosinophilia overview - pediatric resident
DrSheika Bawazir
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
yuyuricci
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritis
Sumit Prajapati
Leptospirosis - clinical manifestations and diagnosis.pdf
Leptospirosis - clinical manifestations and diagnosis.pdfLeptospirosis - clinical manifestations and diagnosis.pdf
Leptospirosis - clinical manifestations and diagnosis.pdf
Jim Jacob Roy
19 Acute Glomerulonephritis
19 Acute Glomerulonephritis19 Acute Glomerulonephritis
19 Acute Glomerulonephritis
ghalan
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptxPresentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
deeasikpo
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
Kamal Mergani
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE  EMERGENCIES.pptxSEPSIS MANGEMENT IN THE  EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
Dr Abd Elaal Elbahnasy
Systemic Lupus-erythmatosus a detailed review.pdf
Systemic Lupus-erythmatosus  a detailed review.pdfSystemic Lupus-erythmatosus  a detailed review.pdf
Systemic Lupus-erythmatosus a detailed review.pdf
UsamaSaleem91
Harrison book based CAP-Report-Jake.pptx
Harrison book based CAP-Report-Jake.pptxHarrison book based CAP-Report-Jake.pptx
Harrison book based CAP-Report-Jake.pptx
ManishShah102081
Pulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxptPulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxpt
drnomanmalikdnm
Blood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptxBlood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptx
VishnuPrasad438933
Sepsis
SepsisSepsis
Sepsis
Abeer Alshare'
Sle complication
Sle complicationSle complication
Sle complication
Marwa Besar
Antibiotics
AntibioticsAntibiotics
Antibiotics
shabeel pn
lecture notes
lecture noteslecture notes
lecture notes
john522129
Pulmonary Sarcoidosis
Pulmonary SarcoidosisPulmonary Sarcoidosis
Pulmonary Sarcoidosis
Sarfraz Saleemi
Leptospirosis notes IM full notes with clinical
Leptospirosis notes IM full notes with clinicalLeptospirosis notes IM full notes with clinical
Leptospirosis notes IM full notes with clinical
drvimalan524
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
dlecolst
Hypereosinophilia overview - pediatric resident
Hypereosinophilia overview - pediatric resident Hypereosinophilia overview - pediatric resident
Hypereosinophilia overview - pediatric resident
DrSheika Bawazir
Leptospirosis
LeptospirosisLeptospirosis
Leptospirosis
yuyuricci
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritis
Sumit Prajapati
Leptospirosis - clinical manifestations and diagnosis.pdf
Leptospirosis - clinical manifestations and diagnosis.pdfLeptospirosis - clinical manifestations and diagnosis.pdf
Leptospirosis - clinical manifestations and diagnosis.pdf
Jim Jacob Roy
19 Acute Glomerulonephritis
19 Acute Glomerulonephritis19 Acute Glomerulonephritis
19 Acute Glomerulonephritis
ghalan
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptxPresentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
Presentation Package on Sepsis & MULTIPLE ORGAN FAILURE.pptx
deeasikpo
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE  EMERGENCIES.pptxSEPSIS MANGEMENT IN THE  EMERGENCIES.pptx
SEPSIS MANGEMENT IN THE EMERGENCIES.pptx
Dr Abd Elaal Elbahnasy
Systemic Lupus-erythmatosus a detailed review.pdf
Systemic Lupus-erythmatosus  a detailed review.pdfSystemic Lupus-erythmatosus  a detailed review.pdf
Systemic Lupus-erythmatosus a detailed review.pdf
UsamaSaleem91
Harrison book based CAP-Report-Jake.pptx
Harrison book based CAP-Report-Jake.pptxHarrison book based CAP-Report-Jake.pptx
Harrison book based CAP-Report-Jake.pptx
ManishShah102081
Pulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxptPulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxpt
drnomanmalikdnm
Blood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptxBlood transfusion Reactions Path - SLIDE SHARE.pptx
Blood transfusion Reactions Path - SLIDE SHARE.pptx
VishnuPrasad438933
Sle complication
Sle complicationSle complication
Sle complication
Marwa Besar
Antibiotics
AntibioticsAntibiotics
Antibiotics
shabeel pn

Recently uploaded (20)

Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa
Endocarditis.pptx
Endocarditis.pptxEndocarditis.pptx
Endocarditis.pptx
Nandish Sannaiah
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma

LEPTOSPIROSIS INFECTION IN CLINICAL ASPECT

  • 2. INTRODUCTION Leptospirosis is a zoonotic disease with protean manifestations Common synonyms include weils disease , rice field fever Mild disease to extremely fatal Imperative to suspect and treat early in order to prevent complications
  • 3. EPIDEMIOLOGY Occurs most commonly in tropics and sub tropics Around 1 million cases reported yearly worldwide with mean case fatality rate of about 10%
  • 4. AGENT Leptospira (thin,spiral ) are spirochetes belonging to the order spirochaetales Nearly 64 species have been identified ,divided into 2 clades and 4 sub clades (p1,p2,s1,s2) Traditionally classified as pathogenic (l.Interrogans) and free living (l. Biflexa) 260 serovars
  • 5. LEPTOSPIROSIS 1.6- 20 micron long and 0.1 micron wide 2. Two polar extrusions 3.Dark field microscopy / silver impregnation staining 4.Special culture media ( fletcher's , Ellinghausen mccullough johnson- harris , or polysorbate 80)
  • 6. HOST Mammals are natural host Humans are incidental hosts ( animal or environmental exposure) Rodents can persistently shed leptospires in urine throughout their lifespan
  • 7. HOST RISK FACTORS Men are more commonly infected Low socioeconomic status - overcrowding and unhygenic Barefoot walking (cuts/abrasions) Recreational exposure - rafting , fresh water swimming Occupational exposure - farmers , sewage workers Domestic animal exposure Travel to endemic areas
  • 9. ENVIRONMENT Damp soil and water Temperature of 28-32 celsius Tropical regions
  • 12. CLINICAL FEATURES MILD DISEASE Majority of cases are mild and go undiagnosed Acute febrile illness / flu like syndrome Fever,headache,rigors,cough Myalgia- calves,backand abdomen
  • 13. CLINICAL FEATURES Conjunctival suffusion Pharyngeal congestion Muscle tenderness Hepatosplenomegaly, lymphadenopathy Meningismus Transient rash
  • 14. SEVERE LEPTOSPIROSIS AND COMPLICATIONS Onset similar to mild disease May not respect the biphasic course of illness Mortality can be as high as 50%
  • 15. SEVERE LEPTOSPIROSIS Hemorrhage Acute renal failure Acute respiratory failure Multiorgan failure Weil syndrome Triad of hemorrhage , jaundice and acute kidney injury SHOCK common presenting sign (45%) due to hypovolemia and microvascular dysregulation
  • 16. CIRCULATORY DYSFUNCTION Hypovolemia occurs in sepsis causes vascular leakage or occur as a consequence of hemorahage Shock Multiorgan dysfunction Hemorrhage manifests due to thrombocytopenia , coagulopathy,vascular endothelial damage
  • 17. RENAL INVOLVEMENT Renal impairment attenuated by dehydration from low fluid intake and high fever Occurs together with jaundice within first 3-4 days presents as non-oliguric ,oliguric or anuric Hyponatremia and hypokalemia due to tubulopathy involving NA-K-2Cl cotransporter Hypokalemia due to impairment of sodium transporter in proximal tubules and spared distal tubules is more common Hypomagnesemia
  • 18. RENAL INVOLVEMENT POLYURIC PHASE: Develop after 10-18 days S.creatinine begins to fall at the end of second week and normalizes within 3-5 weeks In mild cases the only abnormal findings are in urinary sediment includes albuminuria, microscopic hematuria,pyuria and granular casts
  • 19. PULMONARY INVOLVEMENT Occurs in 20-70% of cases Most common symptom is cough Blood tinged sputum or obvious hemoptysis occur Pulmonary hemorrhage minimal or severe diffused leading to respiratory failure Pulmonary edema with cardiomegaly due to volume overload or congestive heart failure from myocarditis Diffuse ground glass opacities without cardiomegaly - ARDS
  • 20. CARDIAC INVOLVEMENT Most commonly non specific st-t changes Myocarditis Conduction abnormality Repolarization abnormalities and arrhthmias
  • 21. CNS INVOLVEMENT Aseptic lymphocytic meningitis Leptospira can be isolated from CSF within 5 days after onset of fever Raised CSF opening pressure Raised protein with normal CSF glucose level Lymphocytic pleocytosis Encephalomyelitis Guillain Barre syndrome Mononeuritis multiplex Cranial nerve palsy Psychiatric syndrome Mania
  • 22. LABORATORY DIAGNOSIS Complete Blood Count Renal Function Tests Liver Function Tests CPK CSF Analysis Urine Analysis CXR,ECG PT,APTT TESTS FOR DIAGNOSIS OF LEPTOSPIROSIS
  • 23. LABORATORY DIAGNOSIS CBC- Leucocytosis( N- 80%)+thrombocytopenia, anaemia++ Thrombocytopenia is a indicator of severe disease. LFT- Elevated billirubin, elevated liver enzymes Markedly Elevated cpk PT, APTT- Prolonged. RFT- AKI+ Urine analysis- proteinuria+, rbcs+ CSF ANALYSIS- ASEPTIC MENINGITIS
  • 24. SUPPORTIVE TESTS Elevated serum amylase Elevated creatinine kinase Cardiac biomarkers Elevated ESR/CRP/Procalcitonin
  • 25. PULMONARY LEPTOSPIROSIS HRCT CHEST Patchy alveolar infiltration Ground glass attenuation Interlobular septa thickening Mediastinal lymphadenitis
  • 26. LABORATORY DIAGNOSIS - SPECIFIC Direct isolation PCR - sensitivity 45-55% Specificity 99-100% Can detect even in first five days of illness Can be done in blood /urine/csf Culture - specificity- 100% Sensitivity - 25% Requires special media Time consuming Blood /csf - first 10 days Urine - 2nd week to 30 days after resolution of illness
  • 27. SEROLOGICAL DIAGNOSIS Microscopic agglutination test (mat) Four fold rise in titre or single value of 1:800 Sensitivity 16-20% Igm-elisa Simple , sensitive Single positive sample adequate for diagnosis becomes positive earlier than mat Indicates current infection Commonly performed Antigen detection: Using monoclonal anti lipl32 antibody based antigen capture ellisa- a cost effective alternative to pcr.
  • 29. LAB CRITERIA FOR DIAGNOSIS OF CURRENT LEPTOSPIROSIS CULTURE POSITIVE MAT-SEROCONVERSION ELISA -POSITIVE
  • 31. Presumptive diagnosis of leptospirosis is made of: Part A or Part A + B Score : 26 or more Part A+B+C (Total) : 25 or more A score between 20 and 25 suggests Leptospirosis as a possible diagnosis. Part A+B is useful for diagnosis in the first week as lab tests would be negative. Part A+B+C is valuable in the second week as lab tests would become positive. It is always necessary to confirm the diagnosis with laboratory tests.
  • 32. Reason for Modification Most cases of leptospirosis are reported in the monsoon and post monsoon seasons. Therfore factors such as rainfall,and contact with contaminated environment have been incorporated with appropriate scores Part (B) ELISA and SAT measures IgM antibodies becomes positive by 5th day ,they are the test of choice for diagnosis of current infection and more over a single sample is adequate . High titres and rising titres of MAT have been given appropriate scores Part (C)
  • 33. MANAGEMENT MILD LEPTOSPIROSIS: FIRST LINE - Doxycycline 100mg BID PO for 10 days ALTERNATIVE Amoxicillin 500mg QID OR 1g q8h OR AMPICILLIN 500MG PO tid OR Azithromycin 1g initially followed by 500 mg OD for 2 more days
  • 34. SEVERE LEPTOSPIROSIS(WEIL SYNDROME) PRIMARY : Penicillin G 1.5 million units IV q 6 hrs for 7 days Ceftriaxone 1gm IV OD for 7 days ALTERNATIVE : Ampicillin 0.5-1 gm q6h Azithromycin 500mg OD for 5 days Cefotaxime 1gm q6h Doxycycline 200mg iv loading dose followed by 100mg iv q12h
  • 35. ROLE OF STEROIDS WHY To reduce or delay the need for ventillatory support To reduce mortality WHOM Patients at high risk of pulmonary hemorrhage AKI plus any of the following Platelet count < 1 lakh MAP < 65 mm of Hg Prolonged PT/APTT Need for ionotropes When Initiate as soon as first sign of pulmonary leptospirosis is detected ( tachypnea, hemoptysis, dyspnea)
  • 36. STEROID REGIMENS Methylprednisolone 500mg IV OD for 3 days with first dose given as bolus within first 12 hrs of onset of respiratory involvement For those with renal failure Methylprednisolone 500mg IV after HD OD for 3 days. After 3rd MP dose or after any episode of hemoptysis give Cyclophosphamide 1g IV as single dose Bolus Methylprednisolone 1g IV OD for 3 das followed b 1mg/kg/day of oral prednisolone for 7 days
  • 37. PREVENTION AND CONTROL Avoid swimming,bathing ,swallowing or submersing head in potentially contaminated freshwater especially after periods of heavy rainfall or flooding Rodent control measures Chemoprophylaxis with weekly doxycycline 200 mg once weekly for 6 weeks Proper drainage of water bodies Vaccination of domestic animals General protective measures ( proper footwear,eyewear,bandage of cuts ,etc)
  • 38. PROGNOSIS - POOR FACTORS AGE>40 YEARS CNS/PULMONARY /SEVERE RENAL INVOLVEMENT MECHANICAL VENTILATION ARRHYTHMIAS AND REPOLARISATION ABNORMALITIES SHOCK LEUCOCYTOSIS
  • 39. REFERENCE MANSON TROPICAL INFECTION HARRISON 21ST EDITION